Absence of CHEK2 mutations in Spanish families with hereditary breast cancer

被引：14

作者：

Bellosillo, B ^{[1
]}

Tusquets, I

Longarón, R

Pérez-Lezaun, A

Bellet, M

Serrano, S

Solé, F

机构：

[1] Hosp Mar, Lab Citogenet & Biol Mol, Serv Patol, Inst Municipal Assistencia Sanitaria, Barcelona, Spain

[2] Univ Pompeu Fabra, Serv Genom, Barcelona, Spain

[3] Hosp Mar, Unitat Recerca Translac Tumors Solids, Unitat Consell Genet, Inst Municipal Assistencia Sanitaria,Serv Oncol, Barcelona, Spain

[4] Hosp Mar, Lab Citogenet & Biol Mol, Unitat Recerca Biomed Barcelona, Inst Municipal Assistencia Sanitaria,Serv Patol, Barcelona, Spain

来源：

CANCER GENETICS AND CYTOGENETICS | 2005年 / 161卷 / 01期

关键词：

D O I：

10.1016/j.cancergencyto.2005.01.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：93 / 95

页数：3

共 21 条

[1] Mutation analysis of the CHK2 gene in families with hereditary breast cancer [J].

Allinen, M ;

Huusko, P ;

Mäntyniemi, S ;

Launonen, V ;

Winqvist, R .

BRITISH JOURNAL OF CANCER, 2001, 85 (02) :209-212

[2] Chk2 kinase - A busy messenger [J].

Bartek, J ;

Falck, J ;

Lukas, J .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (12) :877-886

[3] Focus on breast cancer [J].

Baselga, J ;

Norton, L .

CANCER CELL, 2002, 1 (04) :319-322

[4] Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [J].

Bell, DW ;

Varley, JM ;

Szydlo, TE ;

Kang, DH ;

Wahrer, DCR ;

Shannon, KE ;

Lubratovich, M ;

Verselis, SJ ;

Isselbacher, KJ ;

Fraumeni, JF ;

Birch, JM ;

Li, FP ;

Garber, JE ;

Haber, DA .

SCIENCE, 1999, 286 (5449) :2528-2531

[5] Limited relevance of the CHEK2 gene in hereditary breast cancer [J].

Dufault, MR ;

Betz, B ;

Wappenschmidt, B ;

Hofmann, W ;

Bandick, K ;

Golla, A ;

Pietschmann, A ;

Nestle-Krämling, C ;

Rhiem, K ;

Hüttner, C ;

Von Lindern, C ;

Dall, P ;

Kiechle, M ;

Untch, M ;

Jonat, W ;

Meindl, A ;

Scherneck, S ;

Niederacher, D ;

Schmutzler, RK ;

Arnold, N .

INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (03) :320-325

[6]

Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251

[7] The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis [J].

Falck, J ;

Mailand, N ;

Syljuåsen, RG ;

Bartek, J ;

Lukas, J .

NATURE, 2001, 410 (6830) :842-847

[8] Mutation analysis of the CHK2 gene in breast carcinoma and other cancers [J].

Ingvarsson, S ;

Sigbjornsdottir, BI ;

Chen, HP ;

Hafsteinsdottir, SH ;

Ragnarsson, G ;

Barkardottir, RB ;

Arason, A ;

Egilsson, V ;

Bergthorsson, JT .

BREAST CANCER RESEARCH, 2002, 4 (03)

[9]

Lee SB, 2001, CANCER RES, V61, P8062

[10] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations [J].

Meijers-Heijboer, H ;

van den Ouweland, A ;

Klijn, J ;

Wasielewski, M ;

de Snoo, A ;

Oldenburg, R ;

Hollestelle, A ;

Houben, M ;

Crepin, E ;

van Veghel-Plandsoen, M ;

Elstrodt, F ;

van Duijn, C ;

Bartels, C ;

Meijers, C ;

Schutte, M ;

McGuffog, L ;

Thompson, D ;

Easton, DF ;

Sodha, N ;

Seal, S ;

Barfoot, R ;

Mangion, J ;

Chang-Claude, J ;

Eccles, D ;

Eeles, R ;

Evans, DG ;

Houlston, R ;

Murday, V ;

Narod, S ;

Peretz, T ;

Peto, J ;

Phelan, C ;

Zhang, HX ;

Szabo, C ;

Devilee, P ;

Goldgar, D ;

Futreal, PA ;

Nathanson, KL ;

Weber, BL ;

Rahman, N ;

Stratton, MR .

NATURE GENETICS, 2002, 31 (01) :55-59

← 1 2 3 →